Book a Demo

Resources / Research & Evidence

Research & Evidence

The science behind ambient care.

Care Daily has been awarded more than $8 million in research funding from the National Institute on Aging, part of the National Institutes of Health, and has run multi-year randomized controlled trials with researchers at the University of California, Berkeley. Our earlier papers carry the company's registered name, People Power Company, so that you can match a citation to us.

At a glance

The science behind ambient care
Care Daily has been awarded more than $8 million in research funding from the National...
AmbientMulti-agentPrivacy-firstOpen APIs

What the research shows

Measured outcomes, not marketing claims.

In a peer-reviewed randomized controlled trial, family caregivers using the active Care Daily system reported significantly lower anxiety and better-preserved sleep quality than those in the control group.

$8M+
Awarded to Care Daily in NIA / NIH research funding
RCT
Randomized controlled trial with UC Berkeley investigators
Lower
Anxiety among family caregivers in the intervention group vs. control
Better
Preserved sleep quality in the intervention group vs. control

Peer-reviewed publications

Published, independent, and specific.

Conducted with the Berkeley Psychophysiology Laboratory under Professor Robert W. Levenson.

Clinical Gerontologist · 2025

In-home assistive technology may help protect dementia caregivers from declining sleep efficiency

Randomized controlled trial · Levenson et al.
Population: family caregivers of people with dementiaResult: sleep quality better preserved in the active group vs. controlRelevance: validates ambient support for the people around the patient, not just the patient
View in Clinical Gerontologist (DOI) →
Clinical Gerontologist · 2023

Evaluating in-home assistive technology for dementia caregivers

Randomized controlled trial · UC Berkeley
Population: primary dementia caregivers, 9-month RCT across 63 homesResult: significantly lower caregiver anxiety at the six-month assessmentRelevance: ambient monitoring reduces the invisible burden that drives burnout and placement
Download the publication (PDF) → Or read Berkeley's own write-up of the trial →
GSA Annual Meeting · 2024

In-home technology protects caregivers' sleep

Gerontological Society of America · presented research
Population: dementia caregivers in the homeResult: protected sleep efficiency among caregivers using the systemRelevance: independent scientific venue, reinforcing the sleep findings
Download the publication (PDF) →
NIA Small Business Showcase

Featured: Care Daily

National Institute on Aging
What it is: the NIA's showcase of small businesses advancing aging researchWhy it matters: federal recognition of the research program behind the platformNote: research funding does not imply endorsement
View on nia.nih.gov →

Research partners

Built with the people who study aging for a living.

Our work is conducted with the Berkeley Psychophysiology Laboratory at the University of California, Berkeley, and funded through the National Institute on Aging. That is why the AI Ambient Assistants across every Care Daily solution rest on real science, not a demo.

A family caregiver at home with the person they care for

Funded by the National Institute on Aging

Science this rigorous is rare in our category.Randomized, controlled, peer-reviewed and federally funded, run by investigators at UC Berkeley with colleagues at Stanford, Cornell, Arizona State, Georgetown, the Mayo Clinic, the University of Nebraska Medical Center and UCSF.

Peer-reviewed

Two randomized controlled trials, 241 caregivers.

Both trials are published open access in Clinical Gerontologist, and both are downloadable here in full. A randomized controlled trial is the strongest evidence design there is, and almost nothing in the ambient care category has been tested this way.

Anxiety

In the first trial, 63 family caregivers were randomized to a fully activated system or to a control condition. Caregiver anxiety declined significantly between three and six months in the activated group. It did not decline in the control group.

Sleep

In the second trial, with a national sample of 178 caregivers, sleep efficiency declined significantly over six months in the control group and did not decline in the activated group. The finding is protective: the technology did not make people sleep better, it stopped their sleep getting worse.